SBI Securities’s Adverum Biotechnologies ADVM Stock Holding History

SBI Securities’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-84	Closed	-$381	–	4017
2025 Q3	$381	Hold	84	–	–	﹤0.01%	3081
2025 Q2	$181	Hold	84	–	–	﹤0.01%	3346
2025 Q1	$367	Sell	84 -1	-1%	-$5	﹤0.01%	2993
2024 Q4	$397	Buy	+85	New	+$572	﹤0.01%	2979

SBI Securities's ADVM Position: Q4 2025 in Review

SBI Securities sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 84 shares — an estimated $381 sold.

SBI Securities first reported a position in ADVM in Q4 2024 and held it in 4 quarters. The position peaked at $397 in Q4 2024. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

SBI Securities reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
SBI Securities sold 84 Adverum Biotechnologies shares in Q4 2025, an estimated $381.
SBI Securities first reported a position in Adverum Biotechnologies in Q4 2024 and held it in 4 quarters.
SBI Securities's Adverum Biotechnologies position peaked at $397 in Q4 2024.
0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.